The Effect of Inhibition of Perisynaptic Astrocyte Glycogen Utilization on Depression-Like Behavior

Area of Science:

• Neuroscience
• Biochemistry
• Behavioral Science

Background:

• Astrocytes produce lactate to fuel neuronal activity and synaptic energy demands.
• Disruptions in astrocyte lactate production are implicated in major depressive disorder pathophysiology.
• Understanding astrocyte energy metabolism is crucial for developing novel depression treatments.

Purpose of the Study:

• To investigate the impact of inhibiting perisynaptic astrocyte glycogen utilization on anxiety- and depression-like behaviors.
• To assess these effects in both female and male mice.
• To explore potential therapeutic targets for mood disorders by modulating astrocyte energy pathways.

Main Methods:

• Intrahippocampal administration of 1,4-dideoxy-1,4-imino-D-arabinitol (DAB), a glycogen phosphorylase inhibitor, or saline in female and male mice.
• Behavioral assessments including locomotor activity, open-field test, light-dark box test, tail suspension test, and sucrose preference test were conducted 3 and 5 days post-injection.

Main Results:

• No significant anxiety- or depression-like behavioral changes were observed in male or female mice 3 days post-injection.
• Five days post-injection, male mice showed increased locomotor activity and time in the open-field.
• Female mice exhibited a significant increase in sucrose preference, suggesting altered sugar-craving rather than hedonic behavior.

Conclusions:

• Hippocampal inhibition of glycogen utilization by DAB did not induce anxiety- or depression-like behaviors in mice.
• Observed behavioral changes in males were attributed to increased locomotor activity, not anxiety.
• Increased sucrose preference in females may reflect homeostatic sugar-craving, warranting further investigation into hypothalamic energy metabolism.